Company: NDRA
Filing Date: 2025-10-28
Form Type: DEFA14A
Source: 0001654954-25-012256
Chunk: 0

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-28
Form: DEFA14A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment No. )</div>

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

| ☐ | Preliminary Proxy Statement                                                     |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement                                                      |
| ☒ | Definitive Additional Materials                                                 |
| ☐ | Soliciting Material Pursuant to Rule 14a-12                                     |

| ENDRA LIFE SCIENCES INC.                         |
| (Name of Registrant as Specified in its Charter) |

<div align='center'>___________________________________________________

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)</div>

Payment of Filing Fee (Check all boxes that apply):

| ☒ | No fee required.                                                                                     |
| ☐ | Fee previously paid with preliminary materials.                                                      |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |